A carregar...
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
COMPARZ study revealed no marked differences in terms of the progression free survival and overall survival between sunitinib and pazopanib treatment. Regarding the quality of life and early tumor shrinkage, pazopanib showed more favorable results than sunitinib treatment. A 70-year-old man underwen...
Na minha lista:
| Publicado no: | Case Rep Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6696783/ https://ncbi.nlm.nih.gov/pubmed/31427949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501716 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|